TY  - JOUR

T1  - Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models.

JO  - Int J Geriatr Psychiatry

PY  - 2010/09/15

AU  - Nagy B

AU  - Brennan A

AU  - Brandtmüller A

AU  - Thomas SK

AU  - Sullivan SD

AU  - Akehurst R

ED  - 

DO  - DOI: 10.1002/gps.2551

VL  - 26

IS  - 5

SP  - 483

EP  - 494

Y2  - 2024/09/20

ER  -